相关实验视频

Updated: Jun 19, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.9K

可切除肝细胞癌的新辅助疗法:探索改善预后的策略

Ya-Nan Ma1,2, Xuemei Jiang2, Peipei Song1

  • 1National Center for Global Health and Medicine, Tokyo, Japan.

Bioscience trends
|February 21, 2024
PubMed
概括

新辅助疗法,包括免疫检查点抑制剂,通过减少肝切除后的复发来改善肝细胞癌 (HCC) 的结果. 组合策略是克服治疗耐药性和增强长期生存的关键.

关键词:
临床试验是指临床试验中的临床试验.终点终点终点是一个终点.免疫疗法 免疫疗法复发性 复发性 复发性响应 响应 响应 响应有针对性的治疗.

更多相关视频

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy04:41

Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy

Published on: March 10, 2023

1.2K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

431

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...